Globus Medical
GMED
389 hedge funds and large institutions have $4.23B invested in Globus Medical in 2023 Q1 according to their latest regulatory filings, with 90 funds opening new positions, 106 increasing their positions, 132 reducing their positions, and 82 closing their positions.
443% more call options, than puts
Call options by funds: $39.7M | Put options by funds: $7.31M
10% more first-time investments, than exits
New positions opened: 90 | Existing positions closed: 82
0% more funds holding
Funds holding: 389 → 389 (0)
0.74% less ownership
Funds ownership: 96.88% → 96.14% (-0.74%)
20% less repeat investments, than reductions
Existing positions increased: 106 | Existing positions reduced: 132
24% less capital invested
Capital invested by funds: $5.57B → $4.23B (-$1.33B)
33% less funds holding in top 10
Funds holding in top 10: 9 → 6 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Nuance Investments
Kansas City,
Missouri
|
+$118M |
| 2 |
HRCM
Hawk Ridge Capital Management
Los Angeles,
California
|
+$102M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$97.6M |
| 4 |
Barclays
London,
United Kingdom
|
+$77M |
| 5 |
Janus Henderson Group
London,
|
+$67.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
-$397M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$148M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$107M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$67.1M |
| 5 |
RI
RTW Investments
New York
|
-$55.5M |
GMED Hedge Fund Activity: Q1 2023 in Review
389 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q1 2023, worth a combined $4.23B — down 24% from $5.57B a quarter earlier.
Buyers outnumbered sellers: 90 funds opened new GMED positions and 82 closed out — a net gain of 8 holders — while 106 added to existing stakes and 132 trimmed.
The largest buyer was Nuance Investments, adding an estimated $118M. The largest seller was Kayne Anderson Rudnick Investment Management, cutting an estimated $397M.
- 389 institutional investors held Globus Medical (GMED) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $4.23B of Globus Medical stock for Q1 2023, down 24% quarter-over-quarter.
- 90 funds opened new Globus Medical positions in Q1 2023 and 82 closed out, a net change of +8 holders.
- The largest Globus Medical buyer in Q1 2023 was Nuance Investments, an estimated $118M added.
- The largest Globus Medical seller in Q1 2023 was Kayne Anderson Rudnick Investment Management, an estimated $397M sold.
Based on aggregated 13F filings for Q1 2023.